In Brief This Week: Roche, Foundation Medicine, University of Arizona Cancer Center, and More

NEW YORK (360Dx) – Roche and Foundation Medicine said this week that Roche's wholly owned subsidiary called 062018 Merger Subsidiary has purchased approximately 12.5 million shares of Foundation Medicine's common stock at a price of $137 per share as part Roche's tender offer for the company, which expired at the end of July 30.